Chemogenomics of allosteric binding sites in GPCRs

Drug Discovery Today: Technologies

Volumn 10, Issue 2, 2013, Pages

  Gloriam, David E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE; G PROTEIN COUPLED RECEPTOR; MELANIN CONCENTRATING HORMONE; SOMATOSTATIN RECEPTOR 5;

BINDING SITE; BIOINFORMATICS; CHEMISTRY; CHEMOGENOMICS; CRYSTALLIZATION; DRUG DESIGN; DRUG STRUCTURE; GENOMICS; LIGAND BINDING; MACHINE LEARNING; PHARMACOPHORE; PHYLOGENY; REVIEW;

ALLOSTERIC SITE; ANIMALS; GENOMICS; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84879888098     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.07.010     Document Type: Review

References (40)

1. C.J. Harris, and A.P. Stevens Chemogenomics: structuring the drug discovery process to gene families Drug Discov. Today 11 2006 880 888
2. T.M. Frimurer, and T. Hogberg Drug design of GPCR ligands using physicogenetics and chemogenomics-principles and case studies Curr. Top. Med. Chem. 2011
3. R. Crossley Thematic analysis: a chemogenomic approach to GPCR drug discovery Curr. Top. Med. Chem. 2011
4. E. Nordling, and E. Homan Generalization of a targeted library design protocol: application to 5-HT7 receptor ligands J. Chem. Inf. Comput. Sci. 44 2004 2207 2215
5. N.P. Savchuk Rational design of GPCR-specific combinational libraries based on the concept of privileged substructures T. Oprea, Chemoinformatics in Drug Discovery 2005 Wiley-VCH Verlag GmbH & Co. 287 313
6. D.E. Gloriam Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design J. Med. Chem. 52 2009 4429 4442
7. E. Jacoby Small molecules for chemogenomicsbased drug discovery E. Jacoby, Chemogenomics Knowledge-based Approaches to Drug Discovery 2006 Imperial College Press 1 38
8. K. Bondensgaard Recognition of privileged structures by G-protein coupled receptors J. Med. Chem. 47 2004 888 899
9. N.A. Kratochwil G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey Curr. Top. Med. Chem. 11 2011 1902 1924
10. T. Klabunde Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening J. Med. Chem. 52 2009 2923 2932
11. R. Fredriksson The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol. Pharmacol. 63 2003 1256 1272
12. K. Haga Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist Nature 482 2012 547 551
13. A.C. Kruse Structure and dynamics of the M3 muscarinic acetylcholine receptor Nature 482 2012 552 556
14. A. Manglik Crystal structure of the micro-opioid receptor bound to a morphinan antagonist Nature 2012
15. A.A. Thompson Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic Nature 485 2012 395 399
16. S. Granier Structure of the delta-opioid receptor bound to naltrindole Nature 485 2012 400 404
17. M.A. Hanson Crystal structure of a lipid G protein-coupled receptor Science 335 2012 851 855
18. H. Wu Structure of the human kappa-opioid receptor in complex with JDTic Nature 485 2012 327 332
19. M. Congreve Progress in structure based drug design for G protein-coupled receptors J. Med. Chem. 54 2011 4283 4311
20. N. Weill, and D. Rognan Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands J. Chem. Inf. Model. 49 2009 1049 1062
21. C.R. Andersson Quantitative chemogenomics: machine-learning models of protein-ligand interaction Curr. Top. Med. Chem. 2011
22. D.E. Gloriam The G protein-coupled receptor subset of the rat genome BMC Genomics 8 2007 338-338
23. B. Pirard Structure-based chemogenomics: analysis of protein family landscapes Methods Mol. Biol. 575 2009 281 296
24. T.T. Ashburn, and K.B. Thor Drug repositioning: identifying and developing new uses for existing drugs Nat. Rev. Drug Discov. 3 2004 673 683
25. M. Bieler Assay Related Target Similarity (ARTS)-chemogenomics approach for quantitative comparison of biological targets J. Chem. Inf. Model. 51 2011 1897 1905
26. P. Faure Knowledge-based analysis of multi-potent G-protein coupled receptors ligands Eur. J. Med. Chem. 2010
27. T.I. Oprea, and A. Tropsha Target, chemical and bioactivity databases-integration is key Drug Discov. Today: Technol. 3 2006 357 365
28. E. Dubus Drug repositioning using in silico compound profiling Fut. Med. Chem. 1 2009 1723 1736
29. B.E. Evans Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists J. Med. Chem. 31 1988 2235 2246
30. C.D. Duarte Privileged structures: a useful concept for the rational design of new lead drug candidates Mini. Rev. Med. Chem. 7 2007 1108 1119
31. D.E. Gloriam Chemogenomic discovery of allosteric antagonists at the GPRC6A receptor Chem. Biol. 18 2011 1489 1498
32. N. Weill Chemogenomic approaches for the exploration of GPCR space Curr. Top. Med. Chem. 2011
33. G.J.P. van Westen Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets MedChemComm 2 2011 16 30
34. L. Jacob Virtual screening of GPCRs: an in silico chemogenomics approach BMC Bioinformatics 9 2008 363
35. P. Wellendorph Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids Mol. Pharmacol. 67 2005 589 597
36. E. Jacoby A novel chemogenomics knowledge-based ligand design strategy-application to G protein-coupled receptors Quant. Struct.-Act. Relationship 20 2001 115 123
37. J.A. Ballesteros, and H. Weinstein Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors Methods Neurosci. 25 1995 366 428
38. S.L. Garland, and D.E. Gloriam A ligand's view of target similarity: chemogenomic binding site-directed techniques for drug discovery Curr. Top. Med. Chem. 2011
39. M.P. Sanders A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design J. Med. Chem. 2012
40. M.H. Verheij Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H(4) and the ion channel serotonin 5-HT(3)A Bioorg. Med. Chem. Lett. 21 2011 5460 5464